全文获取类型
收费全文 | 2818篇 |
免费 | 240篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 111篇 |
妇产科学 | 29篇 |
基础医学 | 381篇 |
口腔科学 | 60篇 |
临床医学 | 385篇 |
内科学 | 695篇 |
皮肤病学 | 41篇 |
神经病学 | 183篇 |
特种医学 | 285篇 |
外科学 | 229篇 |
综合类 | 95篇 |
一般理论 | 5篇 |
预防医学 | 176篇 |
眼科学 | 20篇 |
药学 | 187篇 |
中国医学 | 5篇 |
肿瘤学 | 170篇 |
出版年
2023年 | 15篇 |
2022年 | 13篇 |
2021年 | 45篇 |
2020年 | 30篇 |
2019年 | 42篇 |
2018年 | 63篇 |
2017年 | 41篇 |
2016年 | 40篇 |
2015年 | 38篇 |
2014年 | 68篇 |
2013年 | 84篇 |
2012年 | 95篇 |
2011年 | 122篇 |
2010年 | 70篇 |
2009年 | 106篇 |
2008年 | 117篇 |
2007年 | 103篇 |
2006年 | 95篇 |
2005年 | 77篇 |
2004年 | 72篇 |
2003年 | 79篇 |
2002年 | 67篇 |
2001年 | 66篇 |
2000年 | 57篇 |
1999年 | 61篇 |
1998年 | 67篇 |
1997年 | 78篇 |
1996年 | 86篇 |
1995年 | 70篇 |
1994年 | 60篇 |
1993年 | 64篇 |
1992年 | 81篇 |
1991年 | 71篇 |
1990年 | 82篇 |
1989年 | 78篇 |
1988年 | 77篇 |
1987年 | 83篇 |
1986年 | 80篇 |
1985年 | 63篇 |
1984年 | 39篇 |
1983年 | 30篇 |
1982年 | 35篇 |
1981年 | 27篇 |
1980年 | 20篇 |
1979年 | 20篇 |
1978年 | 23篇 |
1977年 | 22篇 |
1976年 | 20篇 |
1975年 | 21篇 |
1974年 | 14篇 |
排序方式: 共有3068条查询结果,搜索用时 15 毫秒
71.
Normocalcaemic hyperparathyroidism is a common biochemical finding, usually identified during an assessment of bone or renal health. Hypercalcaemia must be considered by calculation of adjusted calcium, and a careful history taken to assess dietary calcium intake and for the possibility of a malabsorption syndrome. 25‐hydroxyvitamin D (25OHD) should be measured and replaced if indicated. The management plan for the patient is influenced by the context in which calcium and PTH were measured. In this brief review we describe the assessment of a patient with normocalcaemic hyperparathyroidism. 相似文献
72.
P. Yamauchi J. Crowley P. Kaur L. Spelman R. Warren 《Journal of the European Academy of Dermatology and Venereology》2018,32(7):1066-1074
Biosimilars are highly similar versions of approved branded biologics. In contrast to generics, which are identical copies of the originator medicines, biosimilars are considered unique but related molecules that differ from the originator reference product as well as from each other. Owing to the complexity of biologic medicines, such as therapeutic monoclonal antibodies, minor differences between biosimilars and the reference products are acceptable provided these differences do not result in any clinically meaningful differences in safety or efficacy. In addition, minor changes in structure and function may occur over time in originator biologic products as a result of alterations in production materials (e.g. cell lines), processes or conditions. The developmental process for biosimilars focuses on a ‘totality of evidence’ approach that emphasizes a stepwise investigational process, including comprehensive structural, functional, pharmacologic and clinical assessment for similarity. The goal of the phase 3 clinical development programme for a biosimilar is not to establish efficacy, per se, but to demonstrate that there are no clinically meaningful differences between the proposed biosimilar and the reference product. The requirement to show clinical similarity informs biosimilar study design, including the selection of the patient population, disease state (indication), study endpoints and statistical methods. Based on the clinical trial results in a representative patient population, results may be extrapolated to other indications provided scientific justification is demonstrated based on, among other things, similar mechanism of action in the extrapolated indications. This review presents the current state of knowledge with respect to biosimilars. We aim to provide the practising clinician with a working knowledge of biosimilars as well as provide some practical guidance on their use and potential benefits in treating dermatologic diseases. 相似文献
73.
Screening of candidate biomaterials for alveolar augmentation using a critical‐size rat calvaria defect model
下载免费PDF全文
![点击此处可从《Journal of clinical periodontology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
74.
75.
76.
78.
79.
This study illustrates the parenting experiences of a random sample of members of Mocha Moms, Inc., a national organization dedicated to supporting women of color who predominantly have elected not to work full‐time outside of the home ( www.mochamoms.org ). Using modified grounded theory methods on 25 telephone interviews, we summarized the benefits members reported receiving from participating in Mocha Moms, such as adult friendships and child‐related information/activities. We also reported the parenting challenges they faced. We conclude that the Mocha Moms organization plays a pivotal role for mothers of color who negotiate numerous obstacles as they build positive lives for themselves and their children. 相似文献
80.
We have explored the polymorphism of the glycophorin system in the human erythrocyte membrane using the immunoblotting techniques and examining 52 individuals selected without prior bias as to their serologic state and ten documented serologic variants of M, N, S, s blood group system. Polyclonal antisera to alpha glycophorin and to alpha glycophorin CNBr carboxyl terminal fragment C (residues 82-131) and M and N specific monoclonal antibodies (MoAbs) were used. The first two reagents detect specific regions of the alpha glycophorin molecule and all electrophoretically resolved species of glycophorins immunologically related to alpha and delta glycophorins (delta glycophorin, [alpha-delta] hybrids and other glycophorins with an alteration in the carboxyl terminal segment); the M and N MoAbs identified the glycophorin species containing or lacking the M or N determinant in the amino terminal octapeptide structures. We find that immunoblotting confirmed in all cases the serologically determined phenotype; we also find that polymorphic forms of the glycophorin system are relatively infrequent; immunoblotting, independent from serologic testing, was capable of detecting five mutants, two most likely S-s-U-phenotypes; a new glycophorin species was detected in normal red cells with both antiglycophorin and antipeptide C sera, which is not evident with MoAbs; immunoblots of known glycophorin variants (En(a-), U-, Mg, Mi I, II, III, V, and Sta) confirmed but also extended our knowledge of the abnormal glycophorins involved; and the He+ and Wrb(-) cells showed normal patterns. 相似文献